First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect
By A Mystery Man Writer
Description
First-in-human study of the safety, pharmacokinetics, and
Emerging roles of fatty acid metabolism in cancer and their
The role of fatty acids metabolism on cancer progression and
Emerging roles of fatty acid metabolism in cancer and their
Acetyl-CoA metabolism as a therapeutic target for cancer
Pharmacokinetics and pharmacodynamics of SCT800, a new recombinant
PDF) First-in-human study of the safety, pharmacokinetics, and
Emerging roles of fatty acid metabolism in cancer and their
Acetyl-CoA metabolism as a therapeutic target for cancer
Fatty Acid Synthase Inhibitor - an overview
SciELO - Brasil - Fatty acid synthase as a potential new
Frontiers First-In-Human Study to Assess the Safety
FASN inhibitor TVB-3166 prevents S-acylation of the spike protein
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and
from
per adult (price varies by group size)